Caroline Baumal, Chief Medical Officer: Apellis Pharmaceuticals APLS Sell · Filed 01/21

Trade details

Type: Insider sale
Amount: $37,244.78
Shares · price: 1,882 sh · $19.79 a share
Held after: 89,324 sh
Stock: Apellis Pharmaceuticals APLS
Person: Caroline BaumalChief Medical Officer
Trade date: 26/01/20
Filed: 26/01/21
Days to filing: 1 days

Sold 2.1% of holdings

Share of holding sold: 2.1%

Apellis Pharmaceuticals trades, last 26 weeks

What else happened in Apellis Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/12/21~02/19

Caroline Baumal's recent trades

Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$60.9K
2,797 sh
$60.9K
Filed 01/23
Traded 01/22
Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$77.1K
3,020 sh
$77.1K
Filed 01/06
Traded 01/05
Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$55.5K
1,853 sh
$55.5K
Filed 25/01/21
Traded 25/01/17
Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$95.2K
2,816 sh
$95.2K
Filed 25/01/08
Traded 25/01/06
Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$165.2K
2,751 sh
$165.2K
Filed 24/01/05
Traded 24/01/04

Caroline Baumal, Chief Officer — sold $37.2K of Apellis Pharmaceuticals APLS · 2.1% of holdings | Whalegun